64 related articles for article (PubMed ID: 18922906)
1. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
[TBL] [Abstract][Full Text] [Related]
2. Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma.
Morales-Molina A; Gambera S; Leo A; García-Castro J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737338
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant administration of Semliki Forest virus expressing interleukin-12 combined with attenuated Salmonella eradicates breast cancer metastasis and achieves long-term survival in immunocompetent mice.
Kramer MG; Masner M; Casales E; Moreno M; Smerdou C; Chabalgoity JA
BMC Cancer; 2015 Sep; 15():620. PubMed ID: 26347489
[TBL] [Abstract][Full Text] [Related]
4. The Development and Characterization of a Next-Generation Oncolytic Virus Armed with an Anti-PD-1 sdAb for Osteosarcoma Treatment
Higgins TA; Patton DJ; Shimko-Lofano IM; Eller TL; Molinari R; Sandey M; Ismail A; Smith BF; Agarwal P
Cells; 2024 Feb; 13(4):. PubMed ID: 38391964
[TBL] [Abstract][Full Text] [Related]
5. Synergistic VSV Virotherapy and Carbon Nanotube Photothermal Therapy for Osteosarcoma in Murine Models.
Sakuda T; Oda A; Furuta T; Johan MP; Sakaguchi T; Adachi N
Anticancer Res; 2024 Jan; 44(1):99-105. PubMed ID: 38159977
[TBL] [Abstract][Full Text] [Related]
6. Concurrent expression of
Ma J; Jin C; Čančer M; Wang H; Ramachandran M; Yu D
Mol Ther Oncolytics; 2021 Jun; 21():356-366. PubMed ID: 34141872
[TBL] [Abstract][Full Text] [Related]
7. Polyvalent Diazonium Polymers Provide Efficient Protection of Oncolytic Adenovirus Enadenotucirev from Neutralizing Antibodies while Maintaining Biological Activity In Vitro and In Vivo.
Francini N; Cochrane D; Illingworth S; Purdie L; Mantovani G; Fisher K; Seymour LW; Spain SG; Alexander C
Bioconjug Chem; 2019 Apr; 30(4):1244-1257. PubMed ID: 30874432
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-detargeting proves more effective than
Suryawanshi YR; Nace RA; Russell SJ; Schulze AJ
Mol Ther Oncolytics; 2021 Dec; 23():1-13. PubMed ID: 34589580
[TBL] [Abstract][Full Text] [Related]
9. Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy.
Gujar S; Pol JG; Kumar V; Lizarralde-Guerrero M; Konda P; Kroemer G; Bell JC
Nat Protoc; 2024 May; ():. PubMed ID: 38769145
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 inhibition boosts the therapeutic efficacy of Semliki Forest virus in pediatric osteosarcoma.
Herrador-Cañete G; Zalacain M; Labiano S; Laspidea V; Puigdelloses M; Marrodan L; Garcia-Moure M; Gonzalez-Huarriz M; Marco-Sanz J; Ausejo-Mauleon I; de la Nava D; Hernández-Osuna R; Martínez-García J; Silva-Pilipich N; Gurucega E; Patiño-García A; Hernández-Alcoceba R; Smerdou C; Alonso MM
Mol Ther Oncolytics; 2022 Sep; 26():246-264. PubMed ID: 35949950
[TBL] [Abstract][Full Text] [Related]
11. Expression and Immunogenicity of Recombinant African Swine Fever Virus Proteins Using the Semliki Forest Virus.
Fang N; Yang B; Xu T; Li Y; Li H; Zheng H; Zhang A; Chen R
Front Vet Sci; 2022; 9():870009. PubMed ID: 35615248
[TBL] [Abstract][Full Text] [Related]
12. Viral Vector-Based Melanoma Gene Therapy.
Hromic-Jahjefendic A; Lundstrom K
Biomedicines; 2020 Mar; 8(3):. PubMed ID: 32187995
[TBL] [Abstract][Full Text] [Related]
13. Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors.
Kubo S; Takagi-Kimura M; Kasahara N
Cancer Gene Ther; 2019 Feb; 26(1-2):41-47. PubMed ID: 30042500
[TBL] [Abstract][Full Text] [Related]
14. New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.
Lundstrom K
Biologics; 2018; 12():43-60. PubMed ID: 29445265
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro.
Geiss C; Kis Z; Leuchs B; Frank-Stöhr M; Schlehofer JR; Rommelaere J; Dinsart C; Lacroix J
Viruses; 2017 Oct; 9(10):. PubMed ID: 29039746
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.
Martikainen M; Ruotsalainen J; Tuomela J; Härkönen P; Essand M; Heikkilä J; Hinkkanen A
Br J Cancer; 2017 Jun; 117(1):51-55. PubMed ID: 28557974
[TBL] [Abstract][Full Text] [Related]
18. Oncolytic Alphaviruses in Cancer Immunotherapy.
Lundstrom K
Vaccines (Basel); 2017 Apr; 5(2):. PubMed ID: 28417936
[TBL] [Abstract][Full Text] [Related]
19. Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.
Autio KP; Ruotsalainen JJ; Anttila MO; Niittykoski M; Waris M; Hemminki A; Vähä-Koskela MJ; Hinkkanen AE
BMC Vet Res; 2015 Jul; 11():170. PubMed ID: 26215394
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice.
Li Y; Zhou Q; Hu Z; Yang B; Li Q; Wang J; Zheng J; Cao W
PLoS One; 2015; 10(7):e0132074. PubMed ID: 26161801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
